Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy

References

• Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, Moertel CG. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil–an Eastern Cooperative Oncology Group study. J Clin Oncol. 1985;3:373–378. doi:10.1200/JCO.1985.3.3.3733973648
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer. 1985;56:2563–2568. doi:10.1002/1097-0142(19851201)56:11<2563::aid-cncr2820561104>3.0.co;2-02864997
   PubMed Web of Science ®Google Scholar
• Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer. 1987;60(9):2284–2303. doi:10.1002/1097-0142(19871101)60:9<2284::aid-cncr2820600930>3.0.co;2-v3326653
   PubMed Web of Science ®Google Scholar
• Russo S, Butler J, Ove R, Blackstock AW. Locally advanced pancreatic cancer: a review. Semin Oncol. 2007;34:327–334. doi:10.1053/j.seminoncol.2007.05.00717674961
   PubMed Web of Science ®Google Scholar
• Huguet F, Girard N, Guerche CS, Hennequin C, Mornex F, Azria D. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review. J Clin Oncol. 2009;27:2269–2277. doi:10.1200/JCO.2008.19.792119307501
   PubMed Web of Science ®Google Scholar
• Parsons CM, Sutcliffe JL, Bold RJ. Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg. 2008;15:429–435. doi:10.1007/s00534-007-1240-718670846
   PubMedGoogle Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Liu Z, Jin K, Guo M, et al. Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol. 2017;24(2):561–568. doi:10.1245/s10434-016-5579-3
   PubMed Web of Science ®Google Scholar
• Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1252–1261. doi:10.1053/j.gastro.2013.01.06823622135
   PubMed Web of Science ®Google Scholar
• Birtolo C, Go VL, Ptasznik A, et al. Phosphatidylinositol 3-Kinase: a link betweeninflammation and pancreatic cancer. Pancreas. 2016;45(1):21–31. doi:10.1097/MPA.000000000000053126658038
   PubMed Web of Science ®Google Scholar
• Martin HL, Ohara K, Kiberu A, et al. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J. 2014;44(7):676–682. doi:10.1111/imj.1245324750233
   PubMed Web of Science ®Google Scholar
• Steele CW, Jamieson NB, Evans TR, et al. Exploiting inflammation for therapeutic gain in pancreatic cancer. Br J Cancer. 2013;108(5):997–1003. doi:10.1038/bjc.2013.2423385734
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.00322995477
   PubMed Web of Science ®Google Scholar
• Zambirinis CP, Pushalkar S, Saxena D, Miller G. Pancreatic cancer, inflammation, and microbiome. Cancer J. 2014;20(3):195–202. doi:10.1097/PPO.000000000000004524855007
   PubMed Web of Science ®Google Scholar
• Garcea G, Ladwa N, Neal CP, et al. Preoperative neutrophil to lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg. 2011;35:868–872. doi:10.1007/s00268-011-0984-z21312035
   PubMed Web of Science ®Google Scholar
• Wang DS, Luo HY, Qiu MZ, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29:3092–3100. doi:10.1007/s12032-012-0226-822476808
   PubMed Web of Science ®Google Scholar
• Smith RA, Bosonnet L, Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–472. doi:10.1016/j.amjsurg.2007.12.05718639229
   PubMed Web of Science ®Google Scholar
• Bhatti I, Peacock O, Lloyd G, et al. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197–203. doi:10.1016/j.amjsurg.2009.08.04120122680
   PubMed Web of Science ®Google Scholar
• Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109:416–421. doi:10.1038/bjc.2013.33223799847
   PubMed Web of Science ®Google Scholar
• Shimizu T, Taniguchi K, Asakuma M, et al. Lymphocyte-to-monocyte ratio and prognostic nutritional index predict poor prognosis in patients on chemotherapy for unresectable pancreatic cancer. Anticancer Res. 2019;39(4):2169–2176. doi:10.21873/anticanres.1333130952764
   PubMed Web of Science ®Google Scholar
• Yamada S, Fujii T, Yabusaki N, et al. Clinical implication of inflammation-based prognostic score in pancreatic cancer: glasgow prognostic score is the most reliable parameter. Medicine (Baltimore). 2016;95(18):e3582. doi:10.1097/MD.000000000000486427149487
   PubMed Web of Science ®Google Scholar
• Geng Y, Qi Q, Sun M, et al. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Eur J Surg Oncol. 2015;41(11):1508–1514. doi:10.1016/j.ejso.2015.07.02226343824
   PubMed Web of Science ®Google Scholar
• Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158–2167. doi:10.1002/cncr.3005727152949
   PubMed Web of Science ®Google Scholar
• Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13:158. doi:10.1186/1471-2407-13-15823530866
   PubMed Web of Science ®Google Scholar
• Feng JF, Huang Y, Chen QX. A new inflammation index is useful for patients with esophageal squamous-cell carcinoma. Onco Targets Ther. 2014;7:1811–1815. doi:10.2147/OTT.S6808425336972
   PubMed Web of Science ®Google Scholar
• He X, Zhou T, Yang Y, et al. Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer. Clin Lung Cancer. 2015;16:e165–e171. doi:10.1016/j.cllc.2015.03.00525922292
   PubMed Web of Science ®Google Scholar
• Jank BJ, Kadletz L, Schnöll J, et al. Prognostic value of advanced lung cancer inflammation index in head and neck squamous-cell carcinoma. Eur Arch Otorhinolaryngol. 2019;276(5):1487–1492. doi:10.1007/s00405-019-05381-030877423
   PubMed Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, et al. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study. BMC Cancer. 2019;19(1):241. doi:10.1186/s12885-019-5468-930885163
   PubMed Web of Science ®Google Scholar
• Park YH, Yi HG, Lee MH, Kim CS, Lim JH. Prognostic value of the pretreatment advanced lung cancer inflammation index (ALI) in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Acta Haematol. 2017;137:76–85. doi:10.1159/00045299128076862
   PubMed Web of Science ®Google Scholar
• Topkan E, Yavuz AA, Aydin M, et al. Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma. J Exp Clin Cancer Res. 2008;27:41. doi:10.1186/1756-9966-27-4118808725
   PubMed Web of Science ®Google Scholar
• Yildirim BA, Özdemir Y, Colakoglu T, Topkan E. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy. Pancreatology. 2016;16(4):599–604. doi:10.1016/j.pan.2016.03.00627029854
   PubMed Web of Science ®Google Scholar
• Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vsobservation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–277. doi:10.1001/jama.297.3.26717227978
   PubMed Web of Science ®Google Scholar
• Levolger S, van Vugt JL, de Bruin RW, IJzermans JN. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102:1448–1458. doi:10.1002/bjs.989326375617
   PubMed Web of Science ®Google Scholar
• Kim EY, Kim YS, Seo JY, et al. The relationship between sarcopenia and systemic inflammatory response for cancer cachexia in small cell lung cancer. PLoS One. 2016;11:e0161125. doi:10.1371/journal.pone.016112527537502
   PubMed Web of Science ®Google Scholar
• Hilmi M, Jouinot A, Burns R, et al. Body composition and sarcopenia: the nextgeneration of personalized oncology and pharmacology? Pharmacol Ther. 2019;196:135–159. doi:10.1016/j.pharmthera.2018.12.00330521882
   PubMed Web of Science ®Google Scholar
• Baracos VE, Arribas L. Sarcopenicobesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(suppl–2):ii1–ii9. doi:10.1093/annonc/mdx81029506228
   PubMedGoogle Scholar
• Hamaguchi Y, Kaido T, Okumura S, et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 2016;23:1200–1205. doi:10.1016/j.nut.2016.04.003
   Google Scholar
• Kim EY, Kim N, Kim YS, et al. Prognostic significance of modified advanced lung cancer inflammation index (ALI) in patients with small cell lung cancer- Comparison with original ALI. PLoS One. 2016;11(10):e0164056. doi:10.1371/journal.pone.016405627706243
   PubMed Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argil´es J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799. doi:10.1016/j.clnu.2008.06.01318718696
   PubMed Web of Science ®Google Scholar
• Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF. The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention. JCSM Clin Rep. 2018;3(2):pii: e00065.
   PubMedGoogle Scholar
• Bałan BJ, Zygmanowska E, Radomska-Leśniewska DM. Disorders noticed during development of pancreatic cancer: potential opportunities for early and effective diagnostics and therapy. Cent Eur J Immunol. 2017;42(4):377–382. doi:10.5114/ceji.2017.6869829472816
   PubMed Web of Science ®Google Scholar
• Tenesa A, Theodoratou E, Din FV, et al. Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis. Clin Cancer Res. 2010;16(14):3754–3759. doi:10.1158/1078-0432.CCR-10-043920628028
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, et al. Cancer related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–1081. doi:10.1093/carcin/bgp12719468060
   PubMed Web of Science ®Google Scholar
• Yang S, Wang X, Contino G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011;25(7):717–729. doi:10.1101/gad.201611121406549
   PubMed Web of Science ®Google Scholar
• Aghajan M, Li N, Karin M. Obesity, autophagy and the pathogenesis of liver and pancreatic cancers. J Gastroenterol Hepatol. 2012;27Suppl 2:10–14. doi:10.1111/j.1440-1746.2011.07008.x
   Google Scholar
• Yang A, Herter-Sprie G, Zhang H, et al. Autophagy sustains pancreatic cancer growth through both cell autonomous and non-autonomous mechanisms. Cancer Discov. 2018;8:276–287. doi:10.1158/2159-8290.CD-17-095229317452
   PubMed Web of Science ®Google Scholar
• Saglar E, Unlu S, Babalioglu I, Gokce SC, Mergen H. Assessment of ER Stress and autophagy induced by ionizing radiation in both radiotherapy patients and ex vivo irradiated samples. J Biochem Mol Toxicol. 2014;28(9):413–417.24888459
   PubMed Web of Science ®Google Scholar
• Mukubou H, Tsujimura T, Sasaki R, Ku Y. The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol. 2010;37(4):821–828. doi:10.3892/ijo_0000073220811703
   PubMed Web of Science ®Google Scholar